Generic Pharmaceuticals Businesses for Sale and Investment Opportunities

- Pharmaceutical business located in Dhaka, Bangladesh, has a rich history of 52 years in the industry, having recently been acquired by new management. - The brand, licenses, registrations, client base, and property have been transferred to the new owners. - Was supplying across Bangladesh, the Middle East, and African countries under its own branding. - The business was temporarily closed down three years ago due to personal reasons, but it is now in the process of re-establishing existing contracts and resuming production. - With 43 patents from medical authorities and various licenses including drug manufacturing, IRC, and Export & Import, the company has a strong foundation for pharmaceutical production and distribution. - The pharmaceutical company manufactured a diverse range of drug formulations, including liquid, capsule, tablet, suspension, syrup, injection, aerosol spray & inhaler, injections, bolus, premix powder, premix solutions, and bulk drugs. - Manufactured drug categories include - antibiotics, antibacterials, chemotherapeutics, antiprotozoals, antidiarrhoeal, antidiabetic, antihistamines, NSAIDs, antihypertensives, multivitamins etc. - The company possesses a broad client base, serving wholesalers, pharmacies, hospitals, clinics, and distributors, indicating its reach and potential for growth in both domestic and international markets. - Revenue will be primarily generated through the sale of generic medications, with a focus on cost-effective production and competitive pricing strategies, positioning the business well for market success. - The company is led by experienced professionals with a background in pharmaceutical manufacturing, research, and business management, indicating strong leadership and expertise within the organization. - Had established strong relationships with suppliers of raw materials, regulatory authorities, distribution partners, and healthcare institutions. Have started re-establishing existing contracts and will restart the supply. Will continue to manufacture under the existing brand. - Additionally, the current owners are into manufacturing and supplying medical equipment to hospitals and healthcare facilities, thereby providing an opportunity to establish new contracts.

- Pharmaceutical manufacturing and marketing company based in Dhaka. - Company markets and sells the products under its own brand. - Have 54 approved drugs including oncology, ARV, CNS, bone care, and hormone products. - Company has its own manufacturing unit with a maximum production capacity of 750 million pieces per year. - Products are sold through 26 local distributors and 3 international distributors for Europe, Asia, and Africa.

- The project is to manufacture and supply tablets to the government of Sri Lanka up to 860mln per annum on a buyback guarantee and cost plus 20% margin. - The company can sell also in the private market which has a 40% profit margin. - Own 9.25-acre land valued at USD 1mln approx. - The license is issued and a government buyback agreement is signed. - The project is in plug and play stage where the investor can mobilize immediately. - Commercial manufacturing can commence in 8 months.

- API manufacturing company based in Indore, India. For the past 3 decades, this company has focused on API development, manufacturing, and marketing of APIs and intermediates. It has a state-of-the-art manufacturing facility and is a state GMP-certified plant facility. - This is a research-driven organization – that develops technology, translates it to production, and then delivers it to customers. With a strong commitment to excellence in product quality (which is never compromised) and adherence to strict delivery schedules, they are presently exporting to 14 countries around the world. - The company’s strength lies in providing extended support to its customers. Their success has been validated by what they hold the dearest – product excellence and customer service. The company believes that long-term business is rooted in values and business ethics. - It is one of the leading manufacturers of Tinidazole and Ornidazole, which are considered anti-protozoal molecules, a segment of bulk drugs. Sales have shown an increasing trend. - The company has received Good Manufacturing Practices (GMP) Certificate from the Office of the Controller of Food and Drugs Administration, Madhya Pradesh. Note: this transaction is being handled by an advisory firm based in Rajkot.

- Pharmaceutical manufacturer of generic capsules, tablets, and soft gels. - Manufacturing facility was recently completed and is located on 30,000 sq. m. of owned land. - Annual production capacity of 117 million capsules, 205 million tablets, and 313 million soft gels. - Business has not recorded any sales yet. - Will cater to MENA and the export market as well. - The investor will receive a maximum stake of 51% in the company that owns this manufacturing facility.

- Colombian pharmaceutical company that has been operational for close to 20 years. - We have developed 30 medicines registered with INVIMA under our own brand names. - Products are produced by 6 contract manufacturers in Colombia. - We sell the products to doctors and distributors. - Have 6 big distributors who sell to official entities and over 1,200 doctors prescribe our products regularly in a very well organized CRM.

- Our business is essentially a pharmaceutical marketing company that sells a broad range of medicines from multiple brands to its clients. - We have about 60 clients who are essentially pharmaceutical companies and international distributors in the East African countries like Kenya, Burundi, Malawi, etc. These clients provide us with recurring purchase orders. - The entire revenue of the company is generated through the export of these medicines to our clients. There are no domestic clients. However, we will soon commence undertaking clients in India as well. - Currently, we are dealing in 39 different brand names such as Cipla, Glenmark, etc. The products are supplied on the basis of purchase orders received. Logistics support is outsourced. This line of operations contributing to 100 percent of the company's revenue. - We are now seeking to expand our operations and start our own pharmaceutical brand name & manufacturing unit. The majority of the proceeds from this investment will be used to start the manufacturing unit. - The prospective investor will receive a 50 percent ownership of the entire registered business entity which includes pharma marketing, third-party medicine manufacturing, and generic pharmaceutical brand name lines of operations. These three will simple be different domains services under one company. - Our business is extremely valuable due to the owner's long standing relationships in the industry and enormous growth potential in the future. The valuation is based on our own estimate. - The business is registered in Raigarh, Maharashtra. However, we run operations from Navi Mumbai, Maharashtra. - Our business is entirely debt-free with no outstanding business loans, overdue, or defaults. - The company has two directors. One of them has a 75 percent ownership of the business. The other owns the remaining 25 percent of the business. There are no outside investors or shareholders.

- We are manufacturers of generic pharmaceuticals. - Manufacturing is done by a third party and we sell the products under our brand name. - We give orders to the manufacturers based on the requirement. - We sell our products to 15-20 distributors who further sell them to 3,00-4,000 pharmacies. - Among the competition we hold the number 1 position in market share in the state. - The top hospital & top doctors use & recommend the product. - We do not require too many employees as the manufacturing is done by a third party. - Promoter has 7+ years of experience in the industry. - The business has a food license and a drug license.

- Generic medicine manufacturing company that was started in 1992 and now the operations have been stopped. - We used to produce medicines for other clients. We were a B2B business. - We would like to sell only the assets and not the brand name, legal entity. - Production capacity depends on the type of medicines and it is approx 100 metric tonnes per month. - Company has no loans and is completely owned by the family members. - This purchase would be ideal for an existing company looking for expansion or for a new business. - Business is registered in Kolkata and located in Ahmedabad. - We used to generate an annual turnover of INR 7-8 crore with 18% EBITDA. - Assets include 1,800 sq m land with a building, plant, and machinery. The main machinery is 22 reactors with a combined capacity of 6,500 kilolitres. The size of each reactor is 1,000 to 10,000 litres. More asset details can be shared with the buyer. - If the buyer does not want to purchase the property, it is also available for a long term lease.

Business specializing in manufacturing tablets, capsules, and liquids under its own brand name. Business has more than 35 COPP. Facility is built as per WHO norms with all epoxy flooring and panel false ceiling. Business has the latest machines and a fully developed lab. Have valid approvals and quotas from CBN Gwalior. Currently doing domestic sales but registration going on for export to other countries. Medicines are sold to distributors and wholesalers in Himachal Pradesh and surrounding states.